{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:03:07Z","timestamp":1791925387785,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.diabres.2022.110020","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T11:37:55Z","timestamp":1658489875000},"page":"110020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Safety and efficacy of insulin detemir versus NPH in the treatment of diabetes during pregnancy: Systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0811-8156","authenticated-orcid":false,"given":"Kleoniki I.","family":"Athanasiadou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula A.","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodosios","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Papakonstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Bettina","family":"Haidich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2022.110020_b0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diabres.2018.05.010","article-title":"Prevalence of gestational diabetes and subsequent Type 2 diabetes among U.S. women","volume":"141","author":"Casagrande","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.diabres.2022.110020_b0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.aoa.0000344706.95925.dc","article-title":"Hyperglycemia and Adverse Pregnancy Outcomes","volume":"29","author":"Metzger","year":"2009","journal-title":"Obstet Anesth Dig"},{"key":"10.1016\/j.diabres.2022.110020_b0015","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/17425255.2017.1372423","article-title":"The care of pregestational and gestational diabetes and drug metabolism considerations","volume":"13","author":"Hedrington","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.diabres.2022.110020_b0020","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/dom.12098","article-title":"The use of insulin analogues in pregnancy","volume":"15","author":"Lambert","year":"2013","journal-title":"Diabetes, Obes Metab"},{"key":"10.1016\/j.diabres.2022.110020_b0025","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/14740338.2016.1182153","article-title":"Safety of insulin analogues as compared with human insulin in pregnancy","volume":"15","author":"Toledano","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.diabres.2022.110020_b0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1503\/cmaj.081041","article-title":"Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis","volume":"180","author":"Singh","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.diabres.2022.110020_b0035","first-page":"53","article-title":"NPH insulin: fewer episodes of severe hypoglycemia than analogs and less than one-half the cost","volume":"99","author":"Slawson","year":"2019","journal-title":"Am Fam Physician"},{"issue":"5","key":"10.1016\/j.diabres.2022.110020_b0040","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/dme.13317","article-title":"Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes","volume":"34","author":"Kristensen","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2022.110020_b0045","doi-asserted-by":"crossref","DOI":"10.2337\/diacare.28.5.1107","article-title":"Response Study Investigating the Pharmacodynamic and Pharmacokinetic Properties of the Long-Acting Insulin","volume":"28","author":"Plank","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110020_b0050","first-page":"506","article-title":"Insulin lispro (Humalog), the first marketed insulin analogue: indications, contraindications and need for further study","volume":"158","author":"Puttagunta","year":"1998","journal-title":"CMAJ"},{"key":"10.1016\/j.diabres.2022.110020_b0055","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0149-2918(04)90072-0","article-title":"Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type 1 diabetes mellitus using a basal-bolus regimen","volume":"26","author":"Russell-Jones","year":"2004","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.diabres.2022.110020_b0060","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.2337\/dc14-2090","article-title":"Insulin detemir does not cross the human placenta","volume":"38","author":"Suffecool","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110020_b0065","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00592-021-01845-0","article-title":"Pregnancy outcomes in women with type 1 diabetes using insulin degludec","volume":"59","author":"Ringholm","year":"2022","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2022.110020_b0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/jdi.12721","article-title":"Insulin degludec in the first trimester of pregnancy: report of two cases","volume":"9","author":"Milluzzo","year":"2018","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2022.110020_b0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s13300-018-0532-z","article-title":"Successful outcomes with insulin degludec in pregnancy: a case series","volume":"10","author":"Hiranput","year":"2019","journal-title":"Diabetes Ther"},{"issue":"02","key":"10.1016\/j.diabres.2022.110020_b0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-0038-1676510","article-title":"Effectiveness of Insulin Analogs Compared with Human Insulins in Pregnant Women with Diabetes Mellitus","volume":"41","author":"Santos","year":"2019","journal-title":"Systematic Rev Meta-analysis Rev Bras Ginecol e Obs"},{"key":"10.1016\/j.diabres.2022.110020_b0085","first-page":"372","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"2021","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.diabres.2022.110020_b0090","doi-asserted-by":"crossref","first-page":"87.e1","DOI":"10.1016\/j.ajog.2021.04.223","article-title":"Detemir vs neutral protamine Hagedorn insulin for diabetes mellitus in pregnancy: a comparative effectiveness, randomized controlled trial","volume":"225","author":"Fishel Bartal","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.diabres.2022.110020_b0095","first-page":"1","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.diabres.2022.110020_b0100","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jclinepi.2013.02.004","article-title":"The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses","volume":"66","author":"Mustafa","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.diabres.2022.110020_b0105","doi-asserted-by":"crossref","first-page":"426.e1","DOI":"10.1016\/j.ajog.2015.06.010","article-title":"Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes","volume":"213","author":"Herrera","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.diabres.2022.110020_b0110","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1177\/0962280219889080","article-title":"Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis","volume":"29","author":"McGrath","year":"2020","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10.1016\/j.diabres.2022.110020_b0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001155","article-title":"Comparing the efficacy and safety of insulin detemir versus neutral protamine hagedorn insulin in treatment of diabetes during pregnancy: a randomized, controlled study","volume":"8","author":"Ji","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"10","key":"10.1016\/j.diabres.2022.110020_b0120","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/dc11-2264","article-title":"Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes","volume":"35","author":"Mathiesen","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2022.110020_b0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/14767058.2013.799650","article-title":"A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes","volume":"27","author":"Hod","year":"2014","journal-title":"J Matern Neonatal Med"},{"key":"10.1016\/j.diabres.2022.110020_b0130","doi-asserted-by":"crossref","unstructured":"Khalid M, Rashid M, Khurshid K, Usman M, Naeem H, Aman N. Comparison of detemir versus neutral protamine Hagedorn for management of females presenting with Diabetes during pregnancy. 2020;02:195\u2013200.","DOI":"10.51127\/JAMDCV02I04OA04"},{"key":"10.1016\/j.diabres.2022.110020_b0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/HAB-190385","article-title":"Comparison between the effect of regular human insulin and NPH with novo-rapid and levemir insulin in glycemic control in gestational diabetes","volume":"27","author":"Amini","year":"2019","journal-title":"Hum Antibodies"},{"key":"10.1016\/j.diabres.2022.110020_b0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/2229-3485.159943","article-title":"Common pitfalls in statistical analysis: clinical versus statistical significance","volume":"6","author":"Ranganathan","year":"2015","journal-title":"Perspect Clin Res"},{"issue":"9","key":"10.1016\/j.diabres.2022.110020_b0150","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2337\/dc21-0472","article-title":"Risk of major congenital malformations or perinatal or neonatal death with insulin detemir versus other basal insulins in pregnant women with preexisting diabetes: the real-world evolve study","volume":"44","author":"Mathiesen","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110020_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12884-016-1177-4","article-title":"Design and rationale of a large, international, prospective cohort study to evaluate the occurrence of malformations and perinatal\/neonatal death using insulin detemir in pregnant women with diabetes in comparison with other long-acting insulins","volume":"17","author":"Mathiesen","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.diabres.2022.110020_b0160","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.ajog.2011.10.279","article-title":"Does insulin detemir improve pregnancy outcome in pregnant women with diabetes?","volume":"206","author":"Suffecool","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.diabres.2022.110020_b0165","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/1060028019897897","article-title":"Comparison of Hypoglycemia and Safety Outcomes With Long-Acting Insulins Versus Insulin NPH in Pregestational and Gestational Diabetes","volume":"54","author":"Sleeman","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.diabres.2022.110020_b0170","first-page":"E5","article-title":"Is NPH associated with fewer adverse events than analog basal insulin for adults with T2D?","volume":"70","author":"Lyon","year":"2021","journal-title":"J Fam Pract"},{"key":"10.1016\/j.diabres.2022.110020_b0175","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/ijcp.12904","article-title":"Comparison of the impact of human vs analogue insulins on glycosylated haemoglobin in a population with diabetes mellitus","volume":"70","author":"Machado-Alba","year":"2016","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2022.110020_b0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1463-1326.2008.00934.x","article-title":"Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis","volume":"11","author":"Mannucci","year":"2009","journal-title":"Diabetes, Obes Metab"},{"key":"10.1016\/j.diabres.2022.110020_b0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.diabres.2018.04.035","article-title":"Pharmacotherapy for hyperglycemia in pregnancy \u2013 The new insulins","volume":"145","author":"Toledano","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2022.110020_b0190","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/dom.12106","article-title":"A comparison of insulin detemir and neutral protamine hagedorn (isophane) insulin in the treatment of diabetes: a systematic review","volume":"15","author":"Frier","year":"2013","journal-title":"Diabetes, Obes Metab"},{"key":"10.1016\/j.diabres.2022.110020_b0195","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s13300-015-0143-x","article-title":"Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain","volume":"6","author":"Morales","year":"2015","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2022.110020_b0200","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/DMSO.S156739","article-title":"Evaluating the cost-effectiveness of insulin detemir versus neutral protamine hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach","volume":"11","author":"Pollock","year":"2018","journal-title":"Diabetes, Metab Syndr Obes Targets Ther"},{"key":"10.1016\/j.diabres.2022.110020_b0205","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.2337\/dc12-0971","article-title":"Insulin detemir in pregnancy: a small but significant step forward?","volume":"35","author":"McElduff","year":"2012","journal-title":"Diabetes Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:23:57Z","timestamp":1759173837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722008348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":40,"alternative-id":["S0168822722008348"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110020","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of insulin detemir versus NPH in the treatment of diabetes during pregnancy: Systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110020"}}